RIC GARRISON: Open Payments
NPI 1295814408 · PALMDALE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,237 in 89 payments from 28 companies in 2025. Trend: 2023 $3,883 · 2024 $2,938 · 2025 $2,237
Food & beverage: $2,237
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 6 | $228 |
| AstraZeneca Pharmaceuticals LP | 11 | $205 |
| Merck Sharp & Dohme LLC | 7 | $158 |
| Lilly USA, LLC | 7 | $155 |
| Medtronic, Inc. | 4 | $135 |
| Dexcom, Inc. | 4 | $130 |
| SANOFI PASTEUR INC. | 5 | $118 |
| GENZYME CORPORATION | 1 | $117 |
| Bayer Healthcare Pharmaceuticals Inc. | 4 | $99 |
| Novo Nordisk Inc | 4 | $81 |
Products named: VRAYLAR, Dexcom G6 Transmitter, MOUNJARO, FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE, VERQUVO, AIRSUPRA, Kerendia, INCEPTIV.
Industry payments across CA — which companies pay providers there.
